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tolic velocity (EDV), and PSV ratios to predict vein graft
stenosis1-3,16-19; these parameters have been validated,
compared with angiographically defined stenoses. The use
of angiograms as a gold standard in validating duplex scan
criteria to identify failing grafts is somewhat problematic,
because the true gold standard would correlate with an
important clinical outcome, such as graft thrombosis. The
correlation of thrombosis with specific duplex scan para-
meters is difficult to ascertain, given changes over time in
vein graft, inflow and outflow anatomy, and hemodynam-
ics. The study objective was to characterize duplex scan
parameters, patient factors, and graft characteristics in
thrombosed vein grafts being followed in an intensive sur-
veillance program to assess the prognostic value of these
factors in predicting lower extremity vein graft thrombosis.
METHODS
Patients and protocols. The study population consisted
of 165 grafts enrolled in a duplex ultrasound vein graft sur-
veillance protocol at the University of Washington between
January 1992 and November 1999. All patients with infrain-
guinal vein grafts were considered for inclusion in this study,
with patient refusal to return for follow-up, gaps between
follow-up visits greater than 1 year, and graft failure before
first examination being exclusions to entry. Twenty-three
grafts were revised before entry in the study; 10 had been
revised within 2 weeks of graft placement.
The surveillance protocol consisted of duplex scan
The long-term patency of infrainguinal vein bypass
grafts is of primary importance in the treatment of
patients with lower extremity ischemia. Vein graft steno-
sis often precedes graft failure, and several studies have
shown that duplex ultrasound scan reliably identifies
stenotic lesions in autogenous grafts.1-4 Vein graft sur-
veillance with duplex scanning can improve graft patency
by early identification and correction of graft lesions.5-9
Despite intensive surveillance, 10% to 20% of vein bypass
grafts within the first year and up to 25% within 3 years
of surgery will permanently fail.1,5,8-11 Graft salvage after
occlusion is poor, with 2-year patency rates after revision
as low as 19% to 31%.12-15
In several studies, duplex surveillance parameters have
been defined with peak systolic velocity (PSV), end-dias-
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Objective: The objective of this study was to assess the prognostic value of hemodynamic parameters measured with
duplex ultrasound scan, together with other important graft and patient characteristics, in predicting lower extremity
vein graft thrombosis.
Methods: A total of 165 lower extremity vein grafts were entered prospectively into a postoperative duplex ultrasound
scan surveillance program with examinations performed at 1, 2, 3, 4, 6, 9, 12, 18, and 24 months, and annually there-
after. Duplex scan–derived blood flow velocity measurements were recorded at 1562 patient visits over 7 years. Graft
patency was determined after each visit, and an analysis of factors predictive of vein graft thrombosis was performed
with Poisson regression. 
Results: Thirty-two episodes of first-time graft thrombosis occurred, 23 of which were permanent. One-, 3-, and 5-year
secondary graft patency rates were 90%, 86%, and 79%, respectively. In multivariate analyses, duplex scan velocity mea-
surements predictive of lower extremity graft thrombosis included the maximum velocity ratio (Vr) in association with
a graft stenosis and the mean graft peak systolic velocity (MGV) within nonstenotic portions of the body of the graft.
The incidence of graft thrombosis among grafts without inflow/outflow stenoses, with Vr less than 3.5, and with MGV
50 cm/s or more, was 2.9% per year. Incidence rates were considerably higher among grafts with a of Vr of 3.5 or more
(incidence rate ratio = 7.0; 95% CI, 3.4-14.6) or an MGV less than 50 cm/s (incidence rate ratio = 6.5; 95% CI, 3.3-
13.1). In grafts without identifiable inflow, outflow, or graft stenoses, there was no association between MGV and the
risk of graft thrombosis.
Conclusion: Duplex scan velocity measurements are valid predictors of impending graft thrombosis. A Vr of 3.5 or more
and an MGV less than 50 cm/s are the best predictive measures. Repair of correctable graft lesions with a Vr of 3.5 or
more, or inflow, outflow, or graft lesions associated with an MGV less than 50 cm/s are recommended. Grafts without
detectable inflow, outflow, or graft stenoses, regardless of MGV, may be safely followed. (J Vasc Surg 2001;33:24-31.)
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examinations at 1, 2, 3, 4, 6, 9, 12, and 18 months post-
operatively and annually thereafter. Grafts that developed
a stenosis > 50% were followed monthly until the stenosis
was unchanged for three consecutive monthly visits and
were then reentered into the standard protocol. Revised
grafts were reentered into the initial postoperative surveil-
lance schedule. Intraoperative assessment of grafts with
duplex scanning was not routine. Duplex scans were per-
formed with a Hewlett-Packard Sonos 5500 ultrasonic
duplex scanner (Hewlett-Packard Co, Andover, Mass),
and a 7.5-MHz B-mode probe with a 5.5-MHz pulsed-
wave Doppler flow detector was used. The entire vein
graft and inflow and outflow arteries were scanned. 
Vein graft stenoses were categorized with the velocity
ratio (Vr), PSV, and EDV as previously reported by Bandyk
and published in previous work from our group,10,20 as dis-
played in Table I. Inflow and outflow stenoses included
both new stenoses that developed postoperatively and
those present preoperatively; a Vr of 1.5 was used to cate-
gorize a diameter reduction of more than 50%. The mean
graft PSV (MGV) was calculated by averaging the PSVs
measured along the entire graft excluding the velocities at
any stenotic areas or at the proximal or distal anastomosis.
Revision of vein grafts occurred when a patient had a
return of symptoms, the ankle/brachial index (ABI)
dropped more than 0.15, or the graft developed a stenosis
> 75% according to duplex scan criteria. Because of patient
comorbidities or other factors, however, some grafts that
met these criteria were not revised. Angiography was not
routinely performed before vein graft revision.
Analysis. Duplex scan velocity data from each visit
(PSV, EDV, Vr, MGV, inflow disease > 50%, outflow disease
> 50%), ABIs, use of aspirin or warfarin sodium (Coumadin),
demographic factors (age, sex), patient comorbidities
(hypertension, diabetes, hyperlipidemia, smoking history),
and graft factors (type of autogenous conduit, indication for
placement, vessels used for anastomosis) were collected.
With the exclusion of all duplex scan follow-up that occurred
more than 1 year since the previous visit and all follow-up
after a first-graft thrombosis, data from 1562 visits were ana-
lyzed. Five grafts had more than one episode of thrombosis
(2 episodes in 3 grafts, 3 episodes in 1 graft, and 5 episodes
in 1 graft). Only the first episode of thrombosis was consid-
ered; therefore, in these grafts, duplex scan data were col-
lected only up to the first episode of thrombosis. Grafts
revised during the study remained in the analysis up to the
time of a first episode of thrombosis.
Univariate random effects Poisson regression identi-
fied duplex scan and patient factors associated with graft
thrombosis. Multivariate analysis of factors found to be
significant in the univariate analysis was performed with
stepwise regression with backwards elimination (factors
with P < .10 retained in model). Time between patient vis-
its was included as a covariate in both univariate and mul-
tivariate analysis. Kaplan-Meier survival analysis was used
to determine graft patency.
RESULTS
Patient and graft characteristics. Characteristics of
patients and grafts are shown in Table II. A total of 165 vein
grafts were placed in 141 patients (79 males, 62 females).
The patients’ ages ranged from 14 to 89 years (mean age,
65). Indications for bypass grafting included claudication in
72 limbs (44%), ischemic rest pain in 38 limbs (23%), gan-
grenous tissue loss in 50 limbs (30%), and popliteal
aneurysm or trauma in 5 limbs (3.1%). Most of the grafts
placed were in the reversed position (76%), with the remain-
ing in the in situ (21%) or transposed (4%) position. The
common femoral artery was the inflow vessel in 75% of the
grafts, 39 grafts were to the above-knee popliteal artery
(23.5%), 64 were to the below-knee popliteal artery
(38.5%), and 63 were to infrapopliteal vessels (38%).
Characteristics of thrombosed grafts. There were 32
first episodes of graft thrombosis, of which 20 grafts (64%)
were permanently thrombosed, 2 (6%) were revised and sub-
sequently permanently thrombosed, and 10 (30%) were
revised and remained patent at the end of follow-up. The
mean time between the last duplex scan examination and
thrombosis was 58 days (range, 3 days to 1 year). Primary
patency rates of the vein grafts at 1, 3, and 5 years were 67%,
Table II. Characteristics of grafts
Characteristic Vein grafts
No. of grafts 165
Graft years at risk for thrombosis 286.3
No. of examinations 1562
No. of thromboses 32
% permanent 64
% ultimately permanent 70
Indication for graft placement
Claudication (%) 44
Limb threat (%) 53
Other (%) 3
Orientation
Reversed (%) 76
In situ (%) 21
Transposed (%) 4
Vein type
All saphenous (%) 90
All arm vein (%) 4
Saphenous plus arm vein (%) 4
Saphenous plus prosthetic (%) 1
Distal anastomosis
Above-knee popliteal (%) 23
Below-knee popliteal (%) 39
Tibial (%) 38
Table I. Duplex scanning criteria to define vein graft
stenoses10,20
Diameter reduction (%) Vr Velocity (cm/s)
1-19 < 2.0 PSV < 150
20-49 ≥ 2.0 PSV < 150
50-75 ≥ 2.5 PSV ≥ 150
> 75 ≥ 3.5 EDV ≥ 100
JOURNAL OF VASCULAR SURGERY
26 Gibson et al January 2001
86%, and 43%, and assisted primary patency rates were 88%,
80%, and 71%, respectively. One-, 3-, and 5-year secondary
graft patency rates were 90%, 86%, and 79%, respectively.
Sixty-five percent of the thromboses that occurred had an
associated graft stenosis > 75%, 13% had a 50% to 75% steno-
sis, and 12% of grafts that thrombosed had no significant
graft lesion. 
Factors predictive of graft thrombosis. The graft
years at risk, the incidence rate (IR) of thrombosis per 100
graft years, and the IR ratio for stratified duplex scan
velocity parameters are shown in Table III. With a Vr less
than 2 as a referent category, the IR of graft thrombosis
increased from 3.6 per 100 graft years to 42 per 100 graft
years for a Vr of 3.5 or more (P < .001). There was not a
statistically significant increase in the IR of graft thrombo-
sis among PSV duplex scan categories until the PSV
reached values of 400 cm/s or more, where the IR of
thrombosis was six times that of the referent group (PSV
< 150 cm/s, P < .001). Compared with the referent EDV
group of 0 cm/s, the IR of thrombosis was eightfold
higher for EDVs from 50 to 99 cm/s (P < .001), and 15-
fold higher for EDVs of 100 cm/s or more (P < .001).
Strikingly, the incidence of thrombosis per 100 graft years
was 97.8, when the EDV exceeded 100 cm/s.
The incidence of thrombosis for MGVs of 60 to 69
cm/s was 3.5 times higher than that for MGVs of 80
Table III. Univariate analysis of the association of duplex scan parameters with the risk of graft thrombosis
Graft years Incidence of graft thrombosis IRR
Factor at risk (per 100 graft years) (95% CI) P value
Vrmax
< 2 166.7 3.6 1.0*
2.0-2.5 35.3 8.5 2.4 (0.6, 9.4) .2
2.5-3.5 36.4 11 3.0 (0.8, 10.9) .09
3.5-4.5 19.0 42.1 11.6 (3.6, 36.9) < .001
≥ 4.5 28.8 38.1 10.6 (3.7, 29.8) < .001
PSVmax (cm/s)
< 150 133.1 6.0 1.0*
150-199 50.8 7.9 1.3 (0.4, 4.3) .7
200-299 51.5 13.6 2.2 (0.8, 6.3) .1
300-399 27.5 14.6 2.4 (0.7, 8.2) .2
> 400 23.4 38.4 6.3 (2.3, 17.1) < .001
EDVmax (cm/s)
0 227.6 6.6 1.0*
1-19 22.5 8.9 1.4 (0.4, 5.6) .6
20-49 20.0 20.0 3.1 (1.0, 9.6) .054
50-99 9.8 50.9 7.8 (2.8, 21.6) < .001
≥ 100 6.1 97.8 15.1 (5.6, 40.7) < .001
MGV (cm/s)
≥ 80 126.2 4.0 1.0*
70-79 66.2 7.6 1.9 (0.5, 6.8) .3
60-69 43.6 13.7 3.5 (1.0, 11.6) .04
50-59 26.5 7.6 1.9 (0.3,10.1) .5
< 50 23.7 59.0 14.9 (5.2, 43.0) < .001
MGV change (cm/s)
> 0 78.2 2.6 1.0*
–10 to 0 52.5 1.9 0.7 (0.1, 8.3) .8
–20 to –10 38.6 12.9 5.0 (1.0, 26.6) .06
–30 to –20 40.5 14.8 5.8 (1.1, 29.3) .03
< –30 57.3 26.2 10.2 (2.3, 45.3) .002
Inflow disease (> 50%)
No 249.3 9.2 1.0*
Yes 36.9 24.4 2.6 (1.2, 5.6) .01
Outflow disease (> 50%)
No 241.5 8.7 1.0*
Yes 44.8 24.6 2.8 (1.3, 6.3) .009
ABI
ABI change
≥ 0 194.1 8.2 1.0*
–0.10 to 0 55.0 12.7 1.5 (0.6, 3.8) .4
–0.15 to –0.10 15.3 19.6 2.4 (0.6, 8.7) .2
–0.20 to –0.15 5.5 18.0 2.2 (0.3, 17.2) .5
< –0.2 16.4 30.5 3.7 (1.2, 11.6) .02
*Referent category.
ABI, Ankle/brachial index; EDV, end-diastolic velocity; IRR, incidence rate ratio; max, maximum; MGV, mean graft PSV; PSV, peak systolic velocity; Vr,
velocity ratio.
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cm/s or more (P = .04). MGVs less than 50 cm/s had an
IR of thrombosis per 100 graft years of 59, 15-fold higher
than the referent group (P < .001). Change in the MGV
from the first postoperative value was associated with an
increased incidence of thrombosis when the change
exceeded a drop of 20 cm/s. A drop greater than 30 cm/s
was associated with a 10.2-fold increase in incidence of
graft thrombosis (P = .002).
Inflow and outflow stenoses of 50% or greater were
associated with a 2.6-fold and a 2.8-fold increase in risk of
thrombosis, respectively, (P = .01 and P = .009). Changes
in ABI measurements from the maximum postoperative
value were predictive of graft thrombosis only when a
drop greater than 0.2 units was reached; in this group the
risk of graft thrombosis increased 3.7-fold compared with
an ABI change of zero (P = .02).
A univariate analysis of the association between graft
and patient factors and graft thrombosis is shown in Table
IV. The analysis showed no predictive value for graft
thrombosis in analyzing patient comorbidities. The use of
warfarin sodium (Coumadin) did not alter the risk of graft
thrombosis. The use of aspirin, however, was associated
with a 50% reduction in the IR of graft thrombosis. Graft
orientation and the type of autogenous conduit used had
no association with graft thrombosis. There was no differ-
ence in the incidence of thrombosis when below-knee and
above-knee popliteal bypass grafts were compared; how-
ever, grafts with a tibial distal anastomosis had a 4.7-fold
increase in incidence of thrombosis compared with above-
knee grafts (P = .006). Grafts placed for limb threat had a
3.2-fold increase in risk of thrombosis compared with
grafts placed in patients with claudication (P = .003). 
Factors that remained significant predictors of graft
thrombosis in multivariate regression analysis are displayed
in Table V. Aspirin use was associated with a 65% reduc-
tion in the incidence of thrombosis (P = .005). Vrs of 3.5
or more had a sevenfold increase in incidence of throm-
bosis compared with a Vr less than 2.0 (P < .001). MGVs
less than 50 cm/s were associated with a 6.5-fold increase
in incidence of thrombosis compared with MGVs of 80
cm/s or more (P < .001). Tibial distal anastomoses had an
IR of thrombosis that was 3.6 times higher than above-
knee popliteal anastomoses (P = .001).
A subgroup analysis of risk of graft thrombosis associ-
ated with duplex scan parameters is shown in Table VI. In
grafts without inflow or outflow stenosis, a Vr of 3.5 or
more was associated with a 9.3-fold increase in an IR of
thrombosis compared with a Vr less than or equal to 3.5
(P < .001). In grafts without inflow or outflow disease
with normal (≥ 50 cm/s) MGV, a Vr greater than or equal
to 3.5 still imparted a 4.9-fold increase in the incidence of
thrombosis (P = .02) compared with an IR of graft throm-
bosis of 2.9% per year in such grafts with a Vr less than 3.5.
In grafts with no inflow or outflow disease and no graft
stenoses (Vr < 2.0), there was no association between
MGV and graft thrombosis. Grafts without outflow or
graft stenoses that had an inflow stenosis more than 50%
had a 13.6-fold increase in incidence of thrombosis (P =
.004), whereas those without inflow or graft stenoses and
with an outflow stenosis > 50% had no increase in the inci-
dence of graft failure. 
DISCUSSION
Graft thrombosis remains a significant problem even
in patients enrolled in an intensive vein graft surveillance
program.1,5,8,10 No previous studies have validated spe-
cific duplex scan parameters in terms of their ability to pre-
dict thrombosis of a bypass graft. Because rapid
progression and regression of lesions after graft placement
are common,10 measures that attempt to quantify the
severity of stenosis in a bypass graft are “time-dependent
covariates” in that their values change over time. It is
inherently difficult to study the relationship between time-
dependent covariates and outcome. One option is to study
Table IV. Univariate analysis of the association of graft and patient factors with the risk of graft thrombosis
Graft years Incidence of graft thrombosis IRR
Factor at risk (per 100 graft years) (95% CI) P value
Graft characteristics
Distal anastomosis
AK popliteal 84.9 4.7 1.0*
BK popliteal 116.3 7.7 1.6 (0.5, 5.3) .4
Tibial 85.0 22.3 4.7 (1.6, 14.2) .006
Indication
Nonlimb threat 168.4 5.9 1.0*
Limb threat 115.6 19.0 3.2 (1.5, 6.9) .003
Patient characteristics
Coumadin received
No 227.8 10.1 1.0*
Yes 58.4 15.4 1.5 (0.7, 3.4) .3
Aspirin received
No 124.4 16.1 1.0*
Yes 161.8 7.4 0.5 (0.2, 1.0) .042
*Referent category.
AK, Above-knee; BK, below-knee; IRR, incidence rate ratio.
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this association with a baseline value for the covariate
under the incorrect assumption that this value remains
constant over time. In arteriographic studies, this may be
all that is available or possible because patients may have
only been studied once. Because duplex scanning can be
performed frequently after graft placement, however, we
can account for the changes that occur in the graft over
time when studying the association between hemody-
namic parameters measured with duplex scanning and the
risk of graft thrombosis. 
Although our protocol is to revise vein grafts with > 75%
diameter stenosis, not all patients with this degree of graft
stenosis in our population underwent revision. There are
several reasons why vein grafts with significant lesions were
not revised before thrombosis. Patients may have refused
intervention, patient comorbidities may have precluded revi-
sion, or elective revision might have been scheduled and the
graft failed before this date. The high incidence of significant
stenotic lesions in grafts that thrombosed highlights the
importance of early intervention in grafts with high-grade
stenosis. Because we were able to follow a number of
patients with “at risk” grafts who did not undergo revision,
we were able to determine IRs of graft thrombosis for spe-
cific stratified duplex scan parameters. 
The VR is an accurate predictor of angiographically
documented vein graft stenosis.1-3,17,18,21 Our data show
that there is a strong association between a Vr of 3.5 or
more and graft thrombosis. Adjusting for MGV has mini-
mal effect on this association, suggesting that the mecha-
nism by which increasing Vr increases the risk of thrombosis
is not by decreasing overall graft velocity. The association
between Vr and thrombosis persists in grafts without inflow
and outflow disease and in grafts with normal MGV. The
association between graft thrombosis, PSV, and EDV exists
only when these parameters reach high velocities, more 400
cm/s and more than 50 cm/s, respectively. 
The suggestion that low peak systolic flow velocity
predicts vein graft failure was first made by Bandyk et al.22
A number of investigators have used low flow velocity cri-
teria, typically less than 45 cm/s, to detect at-risk
grafts.16,18,19,21,23,24 There have been no studies, how-
ever, that have identified the ideal “cut point” in terms of
the PSV below which grafts are at risk of failure.
Furthermore, there is no standardization on how a low
flow velocity is measured. Our data show that the inci-
dence of graft thrombosis increases dramatically when the
MGV, obtained from averaging PSVs in the nonstenotic
body of the graft, drops below 50 cm/s. An MGV less
than 50 cm/s is associated with an incidence of thrombo-
sis of 59% per year. Change in the MGV from the first
postoperative value is also of significant prognostic value,
with a drop greater than 20 cm/s increasing the incidence
of thrombosis almost sixfold. 
In the absence of any significant vein graft lesions or
inflow or outflow disease, grafts with a low MGV do not
have an increased risk of thrombosis. Grafts with normal
MGV, no inflow or outflow lesions, and no graft lesions,
have an incidence of thrombosis of only 1.5% per year.
There were no episodes of graft thrombosis in grafts with
an MGV less than 50 cm/s in the absence of graft, inflow,
or outflow lesions. In such grafts, the low MGV may be
due to large vein caliber rather than any flow-limiting
lesions. If a graft had a previously normal MGV and sub-
sequently had an MGV drop of greater than 20 cm/s,
careful investigation for vein graft, inflow, or outflow
lesions, which could be responsible for the change, should
be carried out. If no lesions are discerned with duplex
scanning, arteriography may be warranted to rule out a
significant lesion. 
The impact of inflow and outflow lesions on graft
thrombosis is somewhat controversial. A prospective study
of 231 grafts estimated that inflow stenosis was responsi-
ble for approximately 13% of failed grafts and outflow
stenosis for 8.5%.21 Other studies, however, have ques-
tioned the importance of inflow and outflow stenoses as
contributors to graft failure.25-27 In our investigation,
there was a strong association between inflow disease and
thrombosis in grafts without vein graft lesions or outflow
stenoses, but a much weaker (and statistically nonsignifi-
cant) association between outflow disease and thrombosis
in grafts with no vein graft lesions or inflow disease. 
In recent studies, it has been found that the ABI is a
relatively insensitive tool in determining the progression
of lower extremity disease or graft failure.16,22,28,29-31 Our
data show that a drop in the ABI is associated with an
increased incidence of graft thrombosis only when the
magnitude of the drop from maximum postoperative value
exceeds 0.2. In multivariate analysis, however, change in
the ABI was no longer a significant factor in predicting
failure. Although an ABI drop is an important clinical
Table V. Stepwise Poisson regression analysis of factors associated with graft thrombosis
Factor IRR (95% CI) P value
Aspirin use 0.35 (0.16, 0.73) .005
VR max ≥ 3.5 7.02 (3.39, 14.55) < .0001
MGV < 50 cm/s 6.52 (3.26, 13.07) < .0001
Tibial distal anastomosis (vs popliteal) 3.63 (1.69, 7.77) .001
Incidence of thrombosis in grafts with ASA = 0, VRmax < 3.5, MGVmean ≥ 50, and distal popliteal anastomoses = 2.8 per 100 graft years. Variables in step-
wise regression include Vrmax, EDVmax, MGVmean, inflow disease, number of stenoses > 50%, outflow disease, ABI change, distal anastamosic site, indi-
cation for placement, and aspirin use.
ABI, Ankle/brachial index; EDV, end-diastolic velocity; IRR, incidence rate ratio; max, maximum; MGV, mean graft PSV; Vr, velocity ratio.
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This study has several important limitations. The revi-
sion of grafts with duplex scan–identified lesions biases the
results against finding significant associations between
duplex scan velocity measurements and graft thrombosis.
Patient medications (warfarin sodium [Coumadin],
aspirin) were recorded at each visit. Whether patients were
compliant with their medication regimen and whether they
were still taking aspirin or warfarin sodium (Coumadin) on
the date of graft thrombosis were unknown.
CONCLUSIONS
The prevention of graft thrombosis is the primary goal
of a vein graft surveillance program. The following rec-
ommendations can be made on the basis of our data:
lesions with an associated Vr of 3.5 or more should be
repaired as should any grafts with correctable lesions and
an MGV less than 50 cm/s. Grafts with a Vr less than 3.5
and a normal (≥ 50 cm/s) MGV as well as those with an
MGV less than 50 cm/s and no detectable inflow, outflow,
or graft lesions may be safely followed because the inci-
dence of graft thrombosis in these grafts is low.
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DISCUSSION
Dr John J. Ricotta (Stony Brook, NY). In one of your last
slides when you looked at velocity ratio and the number of grafts
that had no lesion with a velocity ratio, it seemed like there were
no grafts under 50 cm of maximum velocity. It seemed like it
stopped at around 60 or 70. Did you have grafts that were really
low outflow grafts where you couldn’t find a lesion, and what
happened to them? 
Dr Kathleen D. Gibson. Yes, we did. In that slide the bars
represent the incidence of thrombosis. There were grafts with a
velocity under 50 cm/s without graft, inflow, or outflow lesions,
but the incidence of thrombosis was zero in those grafts. There
weren’t very many grafts in that category, but we did have a small
population of them. In those cases, sometimes the vein was very
large, and that was the reason why there was a low graft velocity
but no lesions. 
Dr Donald P. Spadone (Columbia, Mo). Two questions. Very
nice work. The mean graft velocity: is that mean peak velocity, is
that what I’m interpreting? 
Dr Gibson. Yes, it’s the mean peak systolic velocity. We
excluded both anastomotic sites and any areas where there was
stenosis and then averaged all of the peak systolic velocities in the
body of the graft that the technologist took to obtain that value.
Dr Spadone. Did you look at the diastolic velocity in these
grafts, and was there any correlation with failure? 
Dr Gibson. Yes, we did, and actually there was a correlation
with graft failure in the univariate model. Once the end-diastolic
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velocity reached 50 cm/s there was a dramatic increase in inci-
dence of graft failure. The incidence of graft thrombosis per 100
graft years was about 50. When the end-diastolic velocity was
between 20 and 49 cm/s, the incidence was 20 per 100 graft
years, almost reaching statistical significance with a P value of
.054. Once the end-diastolic was greater than 20 cm/s, we
started to see an increase in incidence of failure.
Dr Spadone. Did you look at an odds ratio on that?
Dr Gibson. We looked at an incidence rate ratio (IRR). The IRR
for grafts with an EDV greater than 20 cm/s was 3.1, compared
with the referent group of grafts with an EDV of zero. In grafts with
an EDV at 50 cm/s, the IRR was 7.8. With EDV we see a stepwise
increase in incidence of thrombosis across groups, which means
EDV is a poorer predictor of thrombosis than the velocity ratio. 
Dr J. Dennis Baker (Los Angeles, Calif). Do you routinely
measure the diameters at the points at which you take your veloc-
ity measurements? Often one finds a graft that has two greatly dif-
ferent diameters due to a ligation of a large branch, and the only
way we can make any sense out of these on follow-up studies is to
have the diameters.
Dr Gibson. We don’t measure the diameter per se. However,
our technologists often will comment if they see a change in
diameter that explains an increase in velocity ratio and often puts
the velocity data in the context of what is seen on B mode. 
Dr Jonathan D. Beard (Sheffield, UK). There have been
many studies that have tried to predict graft outcome. Many of
them have suggested criteria, but when applied prospectively the
criteria aren’t as good. So my question is, have you applied your
criteria prospectively to a second group to see if they remain valid?
Dr Gibson. No, we haven’t as we just finished this analysis.
Many of those studies, however, correlate the velocity measure-
ments with graft stenosis rather than graft thrombosis, which we
did in this analysis. Our study is unique in that way. 
Dr Mark A. Mattos (Springfield, Ill). Kathleen, very nice
work. I have a simple question. 
In determining inflow and outflow stenosis effect on graft
patency, how far proximal and how far distal did you scan? If the
anastomosis was at the common femoral, did you scan the entire
iliac to determine if there was a proximal lesion? And say, for
example, if you did a fem-pop below the knee, did you scan all
three tibial vessels to determine an outflow stenosis, or just one?
It would be interesting to know. Thanks. 
Dr Gibson. Our practice is to scan as proximally and distally as
we can. We routinely look at all three tibial vessels and then scan
as proximally as possible, up to the external iliacs. 
Dr Joseph L. Mills (Tucson, Ariz). I enjoyed your paper. I had
one question.
Were you able to stratify, since you had data now for quite a
long time, the progression rate in these lesions that weren’t
repaired, comparing early-appearing lesions with later-appearing
lesions? Did the early lesions progress more rapidly and more
rapidly lead to graft thrombosis?
Dr Gibson. We haven’t done that analysis yet, although it
would be very interesting to do so.
